catalog number :
MBS135040
products full name :
Mouse monoclonal to mouse uPA
products short name :
[uPA]
other names :
[urokinase-type plasminogen activator; Urokinase-type plasminogen activator; urokinase-type plasminogen activator; U-plasminogen activator; plasminogen activator, urokinase]
products gene name :
[PLAU]
other gene names :
[Plau; Plau; uPA; u-PA; U-plasminogen activator; uPA]
uniprot entry name :
UROK_MOUSE
concentration :
3.42 mg/ml. Volume: 0.292 ml. Aliquot: 1 x 1.0mg
storage stability :
Store at -70 degree C. Shelf Life: 5 years from delivery
tested application :
ELISA (EIA), Capture, Western Blot (WB), Immunohistochemistry (IHC) Paraffin
other info1 :
Immunogen: Recombinant full length wild-type mouse protein (Glycosylated). Target Information: Recognises Urokinase (uPA). Target Molecular Weight: 44000
other info2 :
Buffer: 0.05M Sodium Phosphate; 0.15M NaCl; pH 7.4. Extinction Coefficient: 1.36
products categories :
Urokinase (uPA); Monoclonal Antibodies to Mouse uPA
products description :
Capture monoclonal antibody produced in mouse. IgG fraction purified by immobilized Protein A. Isotype IgG.
ncbi acc num :
NP_032899.1
ncbi gb acc num :
NM_008873.3
ncbi mol weight :
160,000
ncbi pathways :
Blood Clotting Cascade Pathway (198388); Complement And Coagulation Cascades Pathway (198335); Complement And Coagulation Cascades Pathway (83270); Complement And Coagulation Cascades Pathway (484); Dissolution Of Fibrin Clot Pathway (765587); Endochondral Ossification Pathway (198336); Hemostasis Pathway (765555); NF-kappa B Signaling Pathway (634537); Proteoglycans In Cancer Pathway (782024); Proteoglycans In Cancer Pathway (782054)
uniprot summary :
uPA: Specifically cleave the zymogen plasminogen to form the active enzyme plasmin. Defects in PLAU are the cause of Quebec platelet disorder (QPD). QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins. Belongs to the peptidase S1 family. 2 isoforms of the human protein are produced by alternative splicing. Protein type: Secreted, signal peptide; Protease; EC 3.4.21.73; Secreted; Motility/polarity/chemotaxis. Cellular Component: extracellular space; focal adhesion; cell surface; membrane; extracellular region. Molecular Function: peptidase activity; hydrolase activity; serine-type peptidase activity; serine-type endopeptidase activity; catalytic activity. Biological Process: wound healing; smooth muscle cell migration; skeletal muscle regeneration; positive regulation of smooth muscle cell migration; proteolysis; regulation of cell proliferation; regulation of cell adhesion mediated by integrin; fibrinolysis; regulation of smooth muscle cell migration; positive regulation of cell proliferation; response to hypoxia; regulation of receptor activity; angiogenesis